| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 106,083 | 104,442 | 108,647 | 165,030 | | Cost of Revenue | 65,350 | 60,978 | 62,100 | 104,656 | | | Gross Profit | 40,733 | 43,464 | 46,547 | 60,374 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 53,177 | 51,211 | 49,833 | 65,650 | | Non Recurring | 250 | 284 | 398 | 5,458 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (12,694) | (8,031) | (3,684) | (10,734) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 57 | 116 | 133 | 342 | | Earnings Before Interest And Taxes | (12,637) | (7,915) | (3,551) | (10,392) | | Interest Expense | 248 | 212 | 731 | 2,848 | | Income Before Tax | (12,885) | (8,127) | (4,282) | (13,240) | | Income Tax Expense | 24 | 22 | 26 | (240) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,909) | (8,149) | (4,308) | (13,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,909) | (8,149) | (4,308) | (13,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,909) | ($8,149) | ($4,308) | ($13,000) |
|
1.52% Nasdaq 
0.09 (3.25%) 
Income Statement
